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ABSTRACT 
The fight against cancer has been a never-ending battle. Limitations of conventional therapies 
include lack of selectivity, poor penetration and highly toxic to the host. Using genetically 
modified bacteria as a tumour therapy agent has gained the interest of scientist from the past 
few decades. Low virulence and highly tolerability of Salmonella spp. in animals and humans 
make it as the most studied pathogen with regards to anti-tumour therapy. The present study 
aims to construct a genetically modified S. Agona auxotroph as an anti-tumour agent. LeuB 
and ArgD metabolic genes in ΔSopBΔSopD double knockout S. Agona were successfully 
knocked out using a Targetron gene knockout system. The knockout was confirmed by 
colony PCR and the strains were characterized in vitro and in vivo. The knockout of 
metabolic genes causes significant growth defect in M9 minimal media. Quadruple knockout 
ΔSopBΔSopDΔLeuBΔArgD (BDLA) exhibited lowest virulence among all of the strains in 
all parameters including bacterial load, immunity profile and histopathology studies. In vivo 
anti-tumour study on colorectal tumour bearing-BALB/c mice revealed that all strains of S. 
Agona were able to suppress the growth of the large solid tumour as compared with negative 
control and ΔLeuBΔArgD (LA) and BDLA auxotroph showed better efficacy. Interestingly, 
higher level of tumour growth suppression was noticed in large tumour. However, multiple 
administration of bacteria dosage did not increase the tumour suppression efficacy. In this 
study, the virulence of BDLA knockout strain was slightly reduced and tumour growth 
suppression efficacy was successfully enhanced, which provide a valuable starting point for 
the development of S. Agona as anti-tumour agent. 
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